Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1234.60
-10.90 (-0.88%)
< Home < Back

Dr. Reddy's Laboratories starts supply of Sputnik V first doses to partner hospitals

Date: 08-09-2021

Dr. Reddy's Laboratories has initiated supply of the first dose component of Russian COVID-19 vaccine Sputnik V to partner hospitals all over the country. The development came following the announcement that Panacea Biotec supplied the first shipment of the second component of the Russian Sputnik V vaccine manufactured by it for sale in India. Dr Reddy's earlier suspended the supply of the first dose of Sputnik V following supply constraints from Russian Direct Investment Fund.

The supply of the first does is followed by equivalent quantities of the second dose component. The company has also launched website to keep the public updated on the availability of the Sputnik V vaccine the site (www.drreddys.com/sputnik-vaccine) contains a list of cities, towns and hospitals where the vaccine is available.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.